-transparent.png){kind=logo}
A recent in silico study by Arnoff and El-Deiry found that urothelial carcinomas of the bladder and upper tract as well as chromophobe renal cell carcinoma are more likely than other malignancies to harbor alterations in the CDKN1A gene, encoding for the cyclin-dependent kinase inhibitor p21Waf1, a major target of p53 regulatory pathways. Most of these mutations were truncating and thus presumably resulting in loss of p21Waf1 function. Herein, we discuss the prognostic and therapeutic implications of these findings.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Omar Alhalabi, and
Pavlos Msaouel
January 1989,
Advances in experimental medicine and biology,
Omar Alhalabi, and
Pavlos Msaouel
October 1992,
Archivos espanoles de urologia,
Omar Alhalabi, and
Pavlos Msaouel
February 2013,
Proteomics,
Omar Alhalabi, and
Pavlos Msaouel
March 2021,
Molecular cancer research : MCR,
Omar Alhalabi, and
Pavlos Msaouel
May 2016,
Molecular & cellular oncology,
Omar Alhalabi, and
Pavlos Msaouel
February 2013,
Journal of fish biology,
Omar Alhalabi, and
Pavlos Msaouel
January 2020,
Mutation research,
Omar Alhalabi, and
Pavlos Msaouel
August 2001,
Current psychiatry reports,
Omar Alhalabi, and
Pavlos Msaouel
November 2019,
The Journal of clinical investigation,
